Log In
BCIQ
Print this Print this
 

Doxovir (CTC-96)

  Manage Alerts
Collapse Summary General Information
Company Opko Health Inc.
DescriptionCobalt containing complex
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPhase II
Standard IndicationConjunctivitis
Indication DetailsTreat adenovirus-derived keratoconjunctivitis; Treat viral conjunctivitis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today